The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Metabolic Modulation With Perhexiline in Chronic Heart Failure: A Randomized, Controlled Trial of Short-Term Use of a Novel Treatment
Open accessAbstract
Background— Chronic heart failure (CHF) is a major cause of morbidity and mortality that requires a novel approach to therapy. Perhexiline is an antianginal drug that augments glucose metabolism by blocking muscle mitochondrial free fatty acid uptake, thereby increasing metabolic efficiency. We assessed the effects of perhexiline treatment in CHF patients. Methods and Results— In a double-blind fashion, we randomly assigned patients with optimally medicated CHF to either perhexiline (n=28) or placebo (n=28). The primary end point was peak exercise oxygen consumption (V̇ o 2 max), an important prognostic marker. In addition, the effect of perhexiline on myocardial function and quality of life was assessed. Quantitative stress echocardiography with tissue Doppler measurements was used to assess regional myocardial function in patients with ischemic CHF. 31 P magnetic resonance spectroscopy was used to assess the effect of perhexiline on skeletal muscle energetics in patients with nonischemic CHF. Treatment with perhexiline led to significant improvements in V̇ o 2 max (16.1±0.6 to 18.8±1.1 mL · kg −1 · min −1 ; P <0.001), quality of life (Minnesota score reduction from 45±5 to 34±5; P =0.04), and left ventricular ejection fraction (24±1% to 34±2%; P <0.001). Perhexiline treatment also increased resting and peak dobutamine stress regional myocardial function (by 15% and 24%, respectively) and normalized skeletal muscle phosphocreatine recovery after exercise. There were no adverse effects during the treatment period. Conclusions— In patients with CHF, metabolic modulation with perhexiline improved V̇ o 2 max, left ventricular ejection fraction, symptoms, resting and peak stress myocardial function, and skeletal muscle energetics. Perhexiline may therefore represent a novel treatment for CHF with a good safety profile, provided that the dosage is adjusted according to plasma levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ommen, S. R., Nishimura, R. A., Appleton, C. P., Miller, F. A., Oh, J. K., Redfield, M. M., & Tajik, A. J. (2000) · Circulation · doi:10.1161/01.cir.102.15.1788 · Cited by 2,790
Cazeau, S., Leclercq, C., Lavergne, T., Walker, S., Varma, C., Linde, C., Garrigue, S., Kappenberger, L., Haywood, G. A., Santini, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103223441202 · Cited by 2,751
Packer, M., Califf, R. M., Konstam, M. A., Krum, H., McMurray, J. J., Rouleau, J.-L., & Swedberg, K. (2002) · Circulation · doi:10.1161/01.cir.0000029801.86489.50 · Cited by 621
Stanley, W. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(96)00245-3 · Cited by 606
Exercise limitation in chronic heart failure: Central role of the periphery
Clark, A. L., Poole-Wilson, P. A., & Coats, A. J. S. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00323-3 · Cited by 524
Rector, T. S., Kubo, S. H., & Cohn, J. N. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90582-w · Cited by 503
Depre, C., Vanoverschelde, J.-L. J., & Taegtmeyer, H. (1999) · Circulation · doi:10.1161/01.cir.99.4.578 · Cited by 425
Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart
Liedtke, A. J. (1981) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(81)90019-0 · Cited by 424
Cohn, J. N., Pfeffer, M. A., Rouleau, J., Sharpe, N., Swedberg, K., Straub, M., Wiltse, C., Wright, T. J., & for the MOXCON Investigators (2003) · European Journal of Heart Failure · doi:10.1016/s1388-9842(03)00163-6 · Cited by 384
Kalra, P. R., Moon, J. C. C., & Coats, A. J. S. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00182-1 · Cited by 293
Lopaschuk, G. D., Wambolt, R. B., & Barr, R. L. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10243-7 · Cited by 265
First clinical trial with etomoxir in patients with chronic congestive heart failure
SCHMIDT-SCHWEDA, S., & HOLUBARSCH, C. (2000) · Clinical Science · doi:10.1042/cs0990027 · Cited by 230
Fragasso, G., Piatti, M., Monti, L., Palloshi, A., Setola, E., Puccetti, P., Calori, G., Lopaschuk, G. D., & Margonato, A. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00415-0 · Cited by 202
Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited
Myers, J., Gullestad, L., Vagelos, R., Do, D., Bellin, D., Ross, H., & Fowler, M. B. (2000) · American Heart Journal · doi:10.1016/s0002-8703(00)90312-0 · Cited by 200
HEUSCH, G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.4.1055 · Cited by 182
Effect of free fatty acids on myocardial function and metabolism in the ischemic dog heart
Kjekshus, J. K., & Mjøs, O. D. (1972) · Journal of Clinical Investigation · doi:10.1172/jci106978 · Cited by 165
Impaired oxidation of debrisoquine in patients with perhexiline liver injury.
Morgan, M. Y., Reshef, R., Shah, R. R., Oates, N. S., Smith, R. L., & Sherlock, S. (1984) · Gut · doi:10.1136/gut.25.10.1057 · Cited by 163
MADLER, C. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00099-x · Cited by 162
Cole, P. L., Beamer, A. D., McGowan, N., Cantillon, C. O., Benfell, K., Kelly, R. A., Hartley, L. H., Smith, T. W., & Antman, E. M. (1990) · Circulation · doi:10.1161/01.cir.81.4.1260 · Cited by 159
Increased uncoupling proteins and decreased efficiency in palmitate-perfused hyperthyroid rat heart
Boehm, E. A., Jones, B. E., Radda, G. K., Veech, R. L., & Clarke, K. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.3.h977 · Cited by 146
Self-citationVescovo, G., Libera, L. D., Serafini, F. M., Leprotti, C., Facchin, L., Volterrani, M., Ceconi, C., & Ambrosio, G. B. (1998) · Circulation · doi:10.1161/01.cir.98.17.1742 · Cited by 142
Napoli, P. D., Taccardi, A. A., & Barsotti, A. (2005) · Heart · doi:10.1136/hrt.2003.031310 · Cited by 141
Belardinelli, R. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2653 · Cited by 128
Fraser, A. G., Payne, N., Madler, C. F., Janerot-Sjoberg, B., Lind, B., Grocott-Mason, R. M., Ionescu, A. A., Florescu, N., Wilkenshoff, U., Lancellotti, P., et al. (2003) · European Heart Journal - Cardiovascular Imaging · doi:10.1053/euje.2002.0610 · Cited by 112
Self-citationKennedy, J. A., Kiosoglous, A. J., Murphy, G. A., Pelle, M. A., & Horowitz, J. D. (2000) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200012000-00016 · Cited by 89
Self-citationKemp, G. J., Thompson, C., Stratton, J. R., Brunotte, F., Conway, M. A., Adamopoulos, S. N., Arnolda, L., Radda, G. K., & Rajagopalan, B. (1996) · Heart · doi:10.1136/hrt.76.1.35 · Cited by 76
Jeffrey, F. M. H., Álvarez, L., Diczku, V., Sherry, A. D., & Malloy, C. R. (1995) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199503000-00018 · Cited by 74
Harrington, D., & Coats, A. J. S. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015194 · Cited by 70
Lodi, R., Kemp, G. J., Muntoni, F., Thompson, C. H., Rae, C. D., Taylor, J., Styles, P., & Taylor, D. J. (1999) · Brain · doi:10.1093/brain/122.1.121 · Cited by 66
MANCINI, D. M., Katz, S. D., Donchez, L., & Aaronson, K. D. (1996) · Circulation · doi:10.1161/01.cir.94.10.2492 · Cited by 65
EFFECT OF FATTY ACIDS ON THE VENTRICULAR ARRHYTHMIA THRESHOLD IN THE ISOLATED HEART OF THE RABBIT
Murnaghan, M. F. (1981) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1981.tb08745.x · Cited by 62
Skeletal muscle metabolism in myotonic dystrophy A 31P magnetic resonance spectroscopy study
Barnes, P. R. J., Kemp, G. J., Taylor, D. J., & Radda, G. K. (1997) · Brain · doi:10.1093/brain/120.10.1699 · Cited by 53
Antman, E. M. (2003) · American Heart Journal · doi:10.1016/j.ahj.2003.09.001 · Cited by 38
Increased Local Metabolic Rate by Free Fatty Acids in the Intact Dog Heart
Mjøs, O. D., & KJEKSHUS, J. K. (1971) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365517109095714 · Cited by 36
Cooke, G. (2002) · European Heart Journal · doi:10.1053/euhj.2001.3112 · Cited by 18
Cited by
The Failing Heart — An Engine Out of Fuel
Neubauer, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmra063052 · Cited by 2,417
Myocardial Fatty Acid Metabolism in Health and Disease
Lopaschuk, G. D., Ussher, J. R., Folmes, C. D. L., Jaswal, J. S., & Stanley, W. C. (2010) · Physiological Reviews · doi:10.1152/physrev.00015.2009 · Cited by 2,179
Cardiac Energy Metabolism in Heart Failure
Lopaschuk, G. D., Karwi, Q. G., Tian, R., Wende, A. R., & Abel, E. D. (2021) · Circulation Research · doi:10.1161/circresaha.121.318241 · Cited by 1,373
Cardiac Metabolism and its Interactions With Contraction, Growth, and Survival of Cardiomyocytes
Kolwicz, S. C., Purohit, S., & Tian, R. (2013) · Circulation Research · doi:10.1161/circresaha.113.302095 · Cited by 813
Cardiovascular remodelling in coronary artery disease and heart failure
Heusch, G., Libby, P., Gersh, B., Yellon, D., Böhm, M., Lopaschuk, G., & Opie, L. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60107-0 · Cited by 734
Metadata
- Authors
- Lee, L., Campbell, R., Scheuermann-Freestone, M., Taylor, R., Gunaruwan, P., Williams, L., Ashrafian, H., Horowitz, J., Fraser, A. G., Clarke, K., & Frenneaux, M.
- Venue
- Circulation
- Published
- 2005-11-22
- Volume
- 112
- Issue
- 21
- Pages
- 3280-3288
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2154258710
- Cited by
- 357
- References
- 35
- FWCI
- 12.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.